SHENZHEN, China, Dec 12, 2014 /PRNewswire/ -- Mindray Medical
International Limited ("Mindray", NYSE: MR), a leading developer,
manufacturer and marketer of medical devices worldwide, today
announced shareholder resolutions adopted at its annual general
meeting of shareholders held in Hong
Kong on December 10, 2014.
At the meeting, Mindray shareholders voted to re-elect incumbent
directors Li Xiting and Kern Lim, each to serve a three-year term.
Mindray's shareholders did not re-elect Peter Wan as a director.
In addition, Mindray shareholders ratified the appointment of
PricewaterhouseCoopers as the Company's independent registered
public accounting firm for the fiscal year ending December 31, 2014.
About Mindray
We are a leading developer, manufacturer and marketer of medical
devices worldwide. We maintain our global headquarters
in Shenzhen, China, U.S.
headquarters in Mahwah, New Jersey and multiple sales
offices in major international markets. From our main manufacturing
and engineering base in China, we supply through our worldwide
distribution network a broad range of products across three primary
business segments, namely patient monitoring and life support,
in-vitro diagnostics, and medical imaging systems. For more
information, please visit: www.mindray.com.
For investor and media inquiries, please contact:
In China:
Cathy Gao
Mindray Medical International Limited
Tel: +86-755-8188-8023
Email: cathy.gao@mindray.com
In the U.S:
Hoki Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email: hoki.luk@westernbridgegroup.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mindray-announced-shareholder-resolutions-post-2014-annual-general-meeting-300009161.html
SOURCE Mindray Medical International Limited